CooperVision has announced the launch of its new myopia control soft contact lens, MyDay MiSight 1 day, that combines the proven ActivControl Technology of MiSight 1 day with the advanced silicone hydrogel material used in MyDay lenses.*1
The lens will be available for wearers in Australia and New Zealand from 2 March 2026.
The introduction of MyDay MiSight 1 day builds on the success of MySight 1 day, the number one fitted soft contact lens brand for myopia control, worn by over 200,000 children worldwide.†2,3
The lens provides the same clear vision and myopia control benefits of the world renowned MiSight 1 day design, with excellent comfort, enhanced ease of handling and breathability over the original MiSight 1 day.‡§◊4,5
Wearers of the new lens will also benefit from a built-in UV inhibitor to help protect the cornea and crystalline lens against transmission of harmful UV radiation.¶
Myopia – a growing challenge
By 2050, myopia is projected to affect half the world’s population. The increasing prevalence of myopia and corresponding clinical and societal impacts necessitate a coordinated global response.6
“CooperVision has spent over a decade building expertise in myopia management across more than 40 countries,” said Michelle North, general manager CooperVision Australia & New Zealand.
“MyDay MiSight 1 day brings together our most advanced contact lens material with an optical design already trusted by hundreds of thousands of parents and children worldwide.*1*
“Myopia is irreversible and typically progresses rapidly in younger children.7 Wearing time is critical for effective myopia control, yet children do not consistently wear their spectacles.**8”
Contact lenses make it easy for children to achieve the maximum wearing time for myopia control.† †4,9,10
In a clinical trial, featuring ActivControl Technology, requiring children to wear contact lenses at least 10 hours per day 6 days per week, children wore their lenses for 13-14 hours per day and more than 6.5 days per week.‡‡9
“MyDay MiSight 1 day contact lenses offer ‘always-on’ myopia control, making it easy for children to achieve maximum myopia control wearing time because children wear them all day,” §§4,9 said Michelle North.
ActivControl Technology used in both MiSight 1 day and MyDay MiSight 1 day has been shown through clinical studies and research spanning 10 years, to slow myopia progression similar to levels seen in emmetropic eyes when worn as prescribed.◊◊5,11
Importantly, the myopia control benefits from ActivControl Technology in MyDay MiSight 1 day were retained after treatment ended.¶¶12
The silicone hydrogel material in the new MyDay MiSight 1 day lens provides up to four times the oxygen transmissibility compared with traditional hydrogel lenses and supports sustained comfort throughout the day.◊13
In clinical evaluations involving children, MyDay MiSight 1 day demonstrated high levels of wearability, including 100% fitting success, excellent handleability and visual acuity measuring better than 6/6.***,†††,‡‡‡,4
Philip Cheng, an optometrist whose practice in Melbourne specialises in myopia management commented, “Having the ActivControl Technology of MiSight 1 day available in a silicone hydrogel material is a welcome development that will benefit many patients.”
Supporting long term vision pathways
The introduction of MyDay MiSight 1 day further strengthens CooperVision’s evidence-based myopia management portfolio.
MyDay MiSight 1 day only differs from MyDay sphere by virtue of its optical design. Patients no longer requiring myopia management can therefore easily transition to single-vision correction contact lenses from the same family once their myopia progression has stabilised, without any need for adaptation or refitting.§§§
References and footnotes
- Chamberlain P et al. A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. OVS 2019;96:556-567.
- CVI Data on file 2025, MiSight 1 day and similar lens types – patients under 20.
- CVI data on file 2025. Internal global wearer modelling estimates for the 12-month period of October 2024 to September 2025
- CVI data on file 2024. Prospective, 1-week, double-masked, randomised, bilateral crossover study with MiSight 1 day and MyDay MiSight 1 day. N=32 subjects aged 8-18 years.
- CVI data on file, 2025
- Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042.
- Zadnik et al. Factors Associated with Rapid Myopia Progression in School-aged Children. IOVS 2004;45(13):2306
- Dhirar N. et al. Compliance to spectacle use in children with refractive errors- a systematic review and meta-analysis. BMC Ophthalmol. 2020 Feb 24;20(1):71.
- Woods J et al. Ocular health of children wearing daily disposable contact lenses over a 6-year period. CLAE 2021 Aug;44(4):101391
- Lumb E, et al. Six years of wearer experience in children participating in a myopia control study of MiSight 1 day. CLAE 2023; 46(4): 101849.] [REF: CVI data on file, 2025. Prospective, 1-week, double masked, bilateral study with MyDay MiSight 1 day. N=32 subjects aged 8-18 years.]
- Chamberlain P, et al. Long-term Effect of Dual-focus Contact Lenses on Myopia Progression in Children: A 6-year Multicenter Clinical Trial. OVS 2022 Mar 1;99(3):204-212.
- Chamberlain P, et al. Eye growth and myopia progression following cessation of myopia control therapy with a dual-focus soft contact lens. OVS 2025; 102(5):353-358. CVI data on file, 2025.
- CVI data on file, 2024
*Proven to slow myopia progression in children compared to a single vision 1-day lens over a 3-year period.
†Based on available fit data in the UK and US for patients under 20
‡Mean score for subjective overall comfort was 90/100 after 1 week of daily wear
§ 94% vs. 81% after 1 week of daily wear, p=NS.
◊Based on manufacturers published data. MyDay MiSight 1 day has Dk/t of 100. Compared to the original MiSight 1 day (Dk/t 28), NaturalVue Multifocal 1 Day (Dk/t 25)
¶ Warning: UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. Patients should continue to use UV-absorbing eyewear as directed
**Compliance with spectacle use in children is highly variable; broken spectacles, loss, forgetfulness, parental and children’s perceptions, peer pressure, and the patient’s self-esteem are a few reasons cited for poor compliance.
†† Studies conducted with MiSight 1 day and MyDay MiSight 1 day.
‡‡ Mean weekday wear time increased from 12.8 hours/day at 6-months to 13.9 hours/day at 6-years with a mean of >6.5 days/week.
§§ In a clinical study, mean weekday wearing time increased from 12.8 hours/day at 6 months to 13.9 hours/day at 6 years with a mean of >6.5 days/week for MiSight 1 day, which shares the same ActivControl Technology with MyDay MiSight 1 day.
◊◊ MyDay MiSight 1 day contact lenses use the same ActivControl Technology as the original MiSight 1 day. In clinical study, the average 3-year elongation in myopes treated with contact lenses with ActivControl Technology approached that of virtual cohorts of emmetropes with the same age distribution.
¶¶ 12 months post-treatment, evidence indicates that no accumulated myopia control benefits were lost following 3 or 6 years of treatment with MiSight 1 day (on average, for children aged 8-15 at start of wear), which shares the same ActivControl Technology with MyDay MiSight 1 day. Instead, eye growth reverted to expected, age average myopic progression rates.
*** 100% fit acceptance with mean scores for fit acceptance (3.4/4).
††† After 1 week of daily wear, 41% rated Excellent (no problems with lens application and removal), 34% rated Very good (occasional difficulty with application and removal), 22% rated Good (some problems with application and removal but usually successful).
‡‡‡ VA (LogMAR) > 6/6 for both study visits (dispense and 1 week).
§§§ MyDay daily disposable
